Medsafe Logo
Hide menus
Show menus


Revised: 22 October 2015

Influenza Vaccine Composition

The recommended trivalent influenza vaccine composition for New Zealand in 2016 is:

For applicants intending to submit a CMN or NMA for a quadrivalent influenza vaccine, the recommended composition for New Zealand in 2016 is as listed above, plus the additional B virus:

Vaccine strains recommended as suitable are those listed on the World Health Organisation (WHO) Influenza vaccine viruses and reagents web pages (see for A(H1N1), A(H3N2) and B viruses.

This recommendation is based on the outcome of:

0 1 2 4 5 6 7 9 [ /